DocDollars

Davol Inc.

RI · United States · Reporting entity ID 100000005490

Total reported 2019–2025
$42.3M
#191 of 2,960 reporting companies — 0.1% of all reported industry payments
$29.4M in general payments across 77,431 records, plus $12.9M in research funding across 428 records.

How it breaks down

General payments $29,394,460
Research funding $12,887,962

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Davol Inc. reported $42.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #191 of 2,960 reporting companies. 30% of that was research funding and 70% general payments such as consulting, speaking, food and travel. 77,431 general payment records and 428 research records were filed.

Common questions about Davol Inc.

How much has Davol Inc. paid US doctors?

Davol Inc. reported $42,282,422 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $29,394,460 in general payments, $12,887,962 in research funding.

How does Davol Inc. rank among drug and device companies?

It ranks #191 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Davol Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.